Norway· NO-ID_63A2022F-D5C0-4729-B66E-5E64C031759F
Aldurazyme
A laronidase product containing laronidase, registered in Norway by Sanofi B.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Laronidase is registered in 12 of 19 countries.
Countries holding a registration under ATC A16AB05 (laronidase), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Laronidase · ATC A16AB05
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Laronidase
- Manufacturer
- Sanofi B.V.
- Country
- Norway (NO)
- ATC code
- A16AB05
- ATC class
- Laronidase
- Defined daily dose
- 1 TSD, E
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_63A2022F-D5C0-4729-B66E-5E64C031759F
- no_varenummer0144391 x 5NOK 7543.8
- gtin358468700018
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for laronidase.
Graded by severity as the source publishes them — 2 minor. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Laronidase · interactions on record
2 records
Same medicine, other countries
Laronidase in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALDURAZYMESanofi B.V., Amsterdam
- United StatesALDURAZYMEGenzyme Corporation
- FinlandAldurazymeOrifarm Oy
- FranceALDURAZYME 100 U/ml, solution à diluer pour perfusionSANOFI (PAYS-BAS)
- United KingdomAldurazyme 500units/5ml concentrate for solution for infusion vialsSanofi
- BelgiumAldurazyme 100 U/mlSanofi
- IcelandAldurazymeGenzyme Europe B.V.
- Japanラロニダーゼ（遺伝子組換え）サノフィ
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Aldurazyme
- Liechtenstein · Aldurazyme
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e5be6568-787e-4f58-a0b5-8596eaeb009a GET /v1/drugs/e5be6568-787e-4f58-a0b5-8596eaeb009a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Laronidase",
"merkevare_id": "ID_63A2022F-D5C0-4729-B66E-5E64C031759F",
"name_form_strength": "Aldurazyme kons til inf oppl 100 E/ml",
"prescription_group": "C"
}See everything about laronidase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.